| Primary |
| Product Used For Unknown Indication |
34.2% |
| Drug Use For Unknown Indication |
20.0% |
| Atrial Fibrillation |
14.6% |
| Arrhythmia |
6.7% |
| Hypertension |
5.0% |
| Atrial Flutter |
4.2% |
| Prostate Cancer |
2.5% |
| Atrial Tachycardia |
1.7% |
| Nodal Arrhythmia |
1.7% |
| Cardiac Failure |
1.3% |
| Angina Pectoris |
0.8% |
| Blood Cholesterol Increased |
0.8% |
| Bronchitis |
0.8% |
| Epilepsy |
0.8% |
| Hernia |
0.8% |
| Hypokalaemia |
0.8% |
| Hypothyroidism |
0.8% |
| Influenza |
0.8% |
| Overdose |
0.8% |
| Pain |
0.8% |
|
| Torsade De Pointes |
9.5% |
| Ventricular Fibrillation |
7.9% |
| Ventricular Tachycardia |
7.9% |
| Hypotension |
6.3% |
| Tachycardia |
6.3% |
| Vomiting |
6.3% |
| Bradycardia |
4.8% |
| Fatigue |
4.8% |
| Overdose |
4.8% |
| Palpitations |
4.8% |
| Syncope |
4.8% |
| Ventricular Extrasystoles |
4.8% |
| Weight Decreased |
4.8% |
| Arrhythmia |
3.2% |
| Headache |
3.2% |
| Nausea |
3.2% |
| Presyncope |
3.2% |
| Sinus Bradycardia |
3.2% |
| Throat Irritation |
3.2% |
| Urinary Retention |
3.2% |
|
| Secondary |
| Atrial Fibrillation |
19.3% |
| Drug Use For Unknown Indication |
18.5% |
| Product Used For Unknown Indication |
13.8% |
| Hypertension |
11.5% |
| Coronary Artery Disease |
5.1% |
| Cardiac Disorder |
4.5% |
| Cardiac Failure |
4.5% |
| Arrhythmia |
4.1% |
| Supraventricular Tachycardia |
2.9% |
| Anxiety |
2.3% |
| Type 2 Diabetes Mellitus |
1.9% |
| Anaesthesia |
1.6% |
| Heart Rate Irregular |
1.4% |
| Ventricular Tachycardia |
1.4% |
| Angina Pectoris |
1.2% |
| Blood Cholesterol Increased |
1.2% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.2% |
| Pain |
1.2% |
| Blood Pressure |
1.0% |
| Cerebrovascular Accident Prophylaxis |
1.0% |
|
| Completed Suicide |
7.8% |
| Transient Ischaemic Attack |
7.8% |
| Renal Failure Acute |
6.7% |
| Therapeutic Response Decreased |
6.7% |
| Ventricular Tachycardia |
6.7% |
| Bradycardia |
5.6% |
| Hypotension |
5.6% |
| Overdose |
5.6% |
| Atrial Fibrillation |
4.4% |
| Drug Ineffective |
4.4% |
| Fatigue |
4.4% |
| Pain |
4.4% |
| Rectal Haemorrhage |
4.4% |
| Syncope |
4.4% |
| Xanthopsia |
4.4% |
| Melaena |
3.3% |
| Presyncope |
3.3% |
| Renal Failure |
3.3% |
| Supraventricular Tachycardia |
3.3% |
| Ventricular Arrhythmia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.3% |
| Atrial Fibrillation |
15.1% |
| Drug Use For Unknown Indication |
11.7% |
| Hypertension |
9.0% |
| Cardiac Disorder |
4.4% |
| Pain |
3.1% |
| Blood Cholesterol Increased |
3.0% |
| Arrhythmia |
2.3% |
| Diabetes Mellitus |
2.1% |
| Cerebrovascular Accident Prophylaxis |
2.1% |
| Prophylaxis |
2.1% |
| Anticoagulant Therapy |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Multiple Myeloma |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Depression |
1.3% |
| Hypothyroidism |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Blood Pressure |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
|
| Weight Decreased |
11.5% |
| Atrial Fibrillation |
8.7% |
| Vomiting |
8.0% |
| Urinary Tract Infection |
7.7% |
| International Normalised Ratio Increased |
5.4% |
| Renal Failure Acute |
5.1% |
| Cerebrovascular Accident |
4.8% |
| Dizziness |
4.2% |
| Pruritus |
4.2% |
| Somnolence |
4.2% |
| Off Label Use |
3.8% |
| Pollakiuria |
3.8% |
| Product Quality Issue |
3.8% |
| Ventricular Tachycardia |
3.8% |
| Drug Ineffective |
3.5% |
| Gastrointestinal Haemorrhage |
3.5% |
| Myocardial Infarction |
3.5% |
| Nausea |
3.5% |
| Sepsis |
3.5% |
| Pain |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
36.4% |
| Hypertension |
25.0% |
| Arrhythmia |
13.6% |
| Acute Myocardial Infarction |
4.5% |
| Atrial Fibrillation |
4.5% |
| Diabetes |
4.5% |
| Blood Pressure |
2.3% |
| Depression |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Influenza |
2.3% |
| Muscle Spasms |
2.3% |
|
| Fatigue |
14.3% |
| Drug Interaction |
9.5% |
| Torsade De Pointes |
9.5% |
| Traumatic Brain Injury |
9.5% |
| Ventricular Arrhythmia |
9.5% |
| Catheterisation Cardiac |
4.8% |
| Dyspnoea |
4.8% |
| Frustration |
4.8% |
| Gynaecomastia |
4.8% |
| Long Qt Syndrome |
4.8% |
| Off Label Use |
4.8% |
| Osteoarthritis |
4.8% |
| Palpitations |
4.8% |
| Presyncope |
4.8% |
| Syncope |
4.8% |
|
